Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiprotozoal drug |
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:ATCCode |
QP51AX
|
| gptkbp:CASNumber |
6298-92-1
|
| gptkbp:hasMolecularFormula |
C19H19NO5
|
| https://www.w3.org/2000/01/rdf-schema#label |
parvaquone
|
| gptkbp:IUPACName |
2-hydroxy-3-[(4-methoxyphenyl)methyl]-1,4-naphthoquinone
|
| gptkbp:mechanismOfAction |
inhibits mitochondrial electron transport
|
| gptkbp:relatedTo |
gptkb:buparvaquone
|
| gptkbp:sideEffect |
local swelling at injection site
|
| gptkbp:target |
Theileria parasites
|
| gptkbp:usedFor |
treatment of theileriosis
|
| gptkbp:usedIn |
gptkb:veterinary_medicine
|
| gptkbp:bfsParent |
gptkb:East_Coast_fever
|
| gptkbp:bfsLayer |
6
|